HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

tafluprost

structure in first source
Also Known As:
1-methylethyl (5Z)-7-((1R,2R, 3R,5S)-2-((1E)-3,3-difluoro-4-phenoxy -1-butenyl)-3,5-dihydroxycyclopentyl)-5-heptenoate; AFP-168
Networked: 155 relevant articles (22 outcomes, 53 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Ropo, Auli: 13 articles (01/2019 - 08/2007)
2. Holló, Gábor: 9 articles (08/2022 - 08/2014)
3. Oddone, Francesco: 6 articles (08/2022 - 01/2020)
4. Kuwayama, Yasuaki: 6 articles (02/2019 - 05/2010)
5. Uusitalo, Hannu: 6 articles (01/2018 - 02/2010)
6. Pfeiffer, Norbert: 6 articles (01/2017 - 05/2010)
7. VISIONARY Study Group: 5 articles (08/2022 - 01/2020)
8. Inoue, Kenji: 5 articles (01/2022 - 01/2013)
9. Katsanos, Andreas: 5 articles (01/2020 - 12/2013)
10. Hashimoto, Masayo: 5 articles (02/2019 - 01/2017)

Related Diseases

1. Glaucoma
2. Open-Angle Glaucoma (Glaucoma, Open Angle)
3. Ocular Hypertension (Glaucoma, Suspect)
4. Low Tension Glaucoma
5. Dry Eye Syndromes (Dry Eye Syndrome)

Related Drugs and Biologics

1. Latanoprost (Xalatan)
2. Timolol (Blocadren)
3. Synthetic Prostaglandins (Prostaglandin Analogues)
4. Travoprost (Travatan)
5. Benzalkonium Compounds (Benzalkonium Chloride)
6. Ophthalmic Solutions (Eye Drops)
7. Prostaglandins
8. Bimatoprost (Lumigan)
9. hydroxide ion
10. Fluorescein (Funduscein)

Related Therapies and Procedures

1. Therapeutics
2. Sutures (Suture)
3. Lasers (Laser)
4. Cataract Extraction